Skip to Content
Panel Session Scaleup International Expansion
Location: ClimbHealth - Wed, 1 Jul 2026 · 14:00 - 14:45 (Europe/London) (45 minutes)

Going Global Early: Internationalisation Strategies That Attract Investment

Overview of session:
International growth can be a powerful driver of credibility and value but only when approached with the right strategy. This session explores how health and life sciences companies can sequence international expansion in a way that supports both commercial success and investor confidence. The panel will cover market timing, overseas structuring, finance, tax and commercial risk, helping businesses understand how to expand with greater clarity and control.

Who should attend?
Founders, CEOs, commercial leaders, export and market access teams, CFOs, investors, and ambitious businesses considering or preparing for international expansion.

Why it’s relevant?
For many growing companies, international ambition is expected but poor timing, weak structures or unmanaged risk can quickly erode value. A credible global strategy can strengthen your growth story, while getting it wrong can create complexity, cost and concern during investment discussions.

What you’ll take away?
You’ll gain practical insight into how to approach international growth in phases, what investors want to see from overseas plans, and the key financial and commercial considerations that should be addressed early.

Speakers
Luke Avon
Luke Avon
Managing Director at Clear Capital Exchange

A high performing, motivated individual with multiple years of experience in sales, account management, HNW client management and business acumen dealing with foreign currency markets.

Rashmi Raju
Rashmi Raju
International Manager

Rashmi joined the Medilink North of England after completing her PhD in Mechanical Engineering from University College London (UCL), where her research focused on maximising the durability of new-generation cardiovascular implants, including transcatheter aortic valves and stent-grafts, through advanced joining and surface engineering methods. Rashmi also have experience working on the orthopaedic biomaterials, having worked on calcium…

Sam Whitehouse
Sam Whitehouse
CEO at Lightox

Experienced CEO and Chairman, scientific entrepreneur with a proven track record of leading high-growth companies in the pharmaceutical, life sciences and medtech sectors. With a background in chemistry and biological sciences, I bring a unique blend of technical insight and commercial acumen to scaling deep tech ventures from concept to market. I thrive at the intersection of science, strategy, and investment—building teams, securing…

Yogan Patel
Yogan Patel
Head of Life Sciences/Pharma/MedTech at MHA Bakertilly Int

Yogan has 30+ years experience as a Chartered Accountant, successfully starting my own London-based partnership in 1991, which became part of a top 20 firm before merging with Top 13 firm MHA, the UK member firm of Baker Tilly International ranked 9th globally. Yogan heads up the Pharma/Life Sciences/MedTech sector and is a member of BIA (BioIndustry Association) FTAC committee. He is a key member of MHA tech sector, managing a…